Back to companies

View up-to-date information on Denali Therapeutics Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.

Number of Deals

image for loader

Deal Value ($M)

Image for Loader
Gain insight into company strategy with premium access to M&A activity Gain insight into company strategy with premium access to M&A activity Contact Us

Latest Deals

Announced Date Headline Deal Type Acquirers/Investors/Surviving Entity Issuer/Partner/Target
27 May 2022 PharmEnable Enters into Collaboration with Denali Therapeutics Partnership -
PharmEnable Ltd  

Denali Therapeutics Inc
28 Feb 2022 Denali Therapeutics to Raise up to USD400 Million in Public Offering of Shares Equity Offering - Denali Therapeutics Inc
13 Oct 2020 Denali Therapeutics Exercises License Option Agreement with Secarna Pharma Licensing Agreement Denali Therapeutics Inc
Secarna Pharmaceuticals GmbH & Co KG  

06 Apr 2021 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit Exercitation cillum velit Tempor
06 Apr 2021 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit Exercitation cillum velit Tempor
06 Apr 2021 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit Exercitation cillum velit Tempor
Explore the latest deals, partnerships, mergers & acquisitions when you unlock full profile Explore the latest deals, partnerships, mergers & acquisitions when you unlock full profile Contact Us
Get in touch about GlobalData Explorer

Contact the team or request a demo to find out how our data can drive your business forward

Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Start of HubSpot Embed Code End of HubSpot Embed Code